Crackdown On Illegal Drugs And Unlicensed Pharmacies In Dimapur

Shillong:  In a bid to combat illegal drug sales and ensure compliance with health regulations, a team from the department of Health & Family Welfare (H&FW), Drug Control, initiated an intensive inspection of drug licenses and the sale of banned drugs in pharmacies across Dimapur. The drive will also cover Chümoukedima district.

Addressing the media at the District Hospital Dimapur (DHD), Health minister P Paiwang Konyak revealed that illegal drugs, banned by the Indian Council of Medical Research (ICMR), were being sold in some pharmacies. He warned that strict action would be taken against any pharmacy found selling such drugs.

The minister stated that the team would also verify the status of pharmacy licenses, ensuring they were properly renewed and that only qualified pharmacists were operating the establishments. He emphasized that any discrepancies would be addressed, and the ongoing checks would continue in the coming days.

Speaking to Nagaland Post, Deputy Drugs Controller Tiatoshi Amer, who also oversees licensing, explained that the state government had already initiated a crackdown on illegal drugs, in line with the ICMR’s ban on certain categories of medications.

He mentioned that some pharmacies had been found selling banned drugs and that these would be thoroughly inspected. If any such drugs were found, the pharmacy’s license would be revoked.

Additionally, the inspection would focus on pharmacies being run by unauthorized or unqualified individuals. Amer emphasized that the authorities had provided ample time for pharmacies to employ qualified pharmacists, and any failure to comply would result in serious consequences.

Pharmacies operating without valid licenses would be issued a show-cause notice, requiring them to renew their licenses. Failure to comply would lead to license cancellation.

Amer also disclosed that 49 licenses had already been suspended, and if any pharmacies were found to be operating with illegal or invalid documents, the team would recommend the cancellation of their licenses to the government.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care